The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors

FEBS Letters

Volumn 587, Issue 12, 2013, Pages 1749-1753

  Imhoff, Floriane M ^a   Yang, Dee ^a   Mathew, Suneeth F ^a   Clarkson, Andrew N ^a   Kawagishi, Yui ^a   Tate, Warren P ^a   Koishi, Kyoko ^a   McLennan, Ian S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Amhr2; Bone morphogenetic protein responsive element; Dominant negative; Kinase domain; Ligand binding domain

Indexed keywords

ANTIMULLERIAN HORMONE TYPE 2 RECEPTOR; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FETUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TESTIS;

ANIMALS; ANTI-MULLERIAN HORMONE; GENE EXPRESSION REGULATION; GENES, REPORTER; MALE; MICE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RATS; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 84878780463     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.04.014     Document Type: Article

References (39)

1. D.T. MacLaughlin, and P.K. Donahoe Sex determination and differentiation New Engl. J. Med. 350 2004 367 378
2. X. Wu, R. Arumugam, S.P. Baker, and M.M. Lee Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice Endocrinology 146 2005 589 595
3. P.Y. Wang, K. Koishi, A.B. McGeachie, M. Kimber, D.T. Maclaughlin, P.K. Donahoe, and I.S. McLennan Mullerian inhibiting substance acts as a motor neuron survival factor in vitro Proc. Natl. Acad. Sci. USA 102 2005 16421 16425
4. P.Y. Wang, A. Protheroe, A.N. Clarkson, F. Imhoff, K. Koishi, and I.S. McLennan Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior Proc. Natl. Acad. Sci. USA 106 2009 7203 7208
5. K. Morgan, J. Meredith, J.-Y.A. Kuo, D.K. Bilkey, and I.S. McLennan The sex bias in novelty preference of preadolescent mouse pups may require testicular Müllerian inhibiting substance Behav. Brain Res. 221 2011 304 306
6. E.A. Catlin, V.C. Tonnu, R.G. Ebb, B.A. Pacheco, T.F. Manganaro, R.M. Ezzell, P.K. Donahoe, and J. Teixeira Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung Endocrinology 138 1997 790 796
7. M.M. Lee Mullerian inhibiting substance in humans: normal levels from infancy to adulthood J. Clin. Endocrinol. Metab. 81 1996 571 576
8. L. Aksglaede Changes in Anti-Mullerian Hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years J. Clin. Endocrinol. Metab. 95 2010 5357 5364
9. K. Morgan, N.A. Dennis, T. Ruffman, D.k. Bilkey, and I.S. McLennan The stature of boys is inversely correlated to the levels of their Sertoli cell hormones: do the testes restrain the maturation of boys? PLoS One 6 2011 e20533
10. D.B. Seifer, V.L. Baker, and B. Leader Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States Fertil. Steril. 95 2011 747 750
11. S. Allard, P. Adin, L. Gouedard, N. di Clemente, N. Josso, M.C. Orgebin-Crist, J.Y. Picard, and F. Xavier Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin Development 127 2000 3349 3360
12. R.L. Parry, T.W. Chin, J. Epstein, P.L. Hudson, D.M. Powell, and P.K. Donahoe Recombinant human Müllerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo Cancer Res. 52 1992 1182 1186
13. J. Teixeira, E. Fynn-Thompson, A.H. Payne, and P.K. Donahoe Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level Endocrinology 140 1999 4732 4738
14. C. Belville, S.P. Jamin, J.Y. Picard, N. Josso, and N. di Clemente Role of type I receptors for anti-Mullerian hormone in the SMAT-1 Sertoli cell line Oncogene 24 2005 4984 4992
15. R. Pieretti-Vanmarcke Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo Clin. Cancer Res. 12 2006 1593 1598
16. N.A. Dennis Is anti-Mullerian hormone a hormone. In anatomy 2012 University of Otago Dunedin
17. S.E. Appt, H. Chen, T.B. Clarkson, and J.R. Kaplan Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis Menopause 19 2012 1353 1359
18. R. Robeva, A. Tomova, G. Kirilov, and P. Kumanov Anti-Mullerian hormone and inhibin B levels reflect altered Sertoli cell function in men with metabolic syndrome Andrologia 44 Suppl. 1 2012 329 334
19. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
20. J.W. Lowery, and M.P. de Caestecker BMP signaling in vascular development and disease Cytokine Growth Factor Rev. 21 2010 287 298
21. N. di Clemente Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta Mol. Endocrinol. 24 2010 2193 2206
22. S. Imbeaud Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor Nat. Genet. 11 1995 382 388
23. I. Salhi The anti-Mullerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand Biochem. J. 379 2004 785 793
24. C.Y. Andersen, K.T. Schmidt, S.G. Kristensen, M. Rosendahl, A.G. Byskov, and E. Ernst Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles Hum. Reprod. 25 2010 1282 1287
25. J. Teixeira Developmental expression of a candidate mullerian inhibiting substance type II receptor Endocrinology 137 1996 160 165
26. N. di Clemente Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone Mol. Endocrinol. 8 1994 1006 1020
27. G.D. Orvis Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse Biol. Reprod. 78 2008 994 1001
28. N. Renlund, R. Pieretti-Vanmarcke, F.H. O'Neill, L. Zhang, P.K. Donahoe, and J. Teixeira C-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction Endocrinology 149 2008 108 115
29. D.L. Segev Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo Proc. Natl. Acad. Sci. USA 99 2002 239 244
30. K.R. Stone, D.D. Mickey, H. Wunderli, G.H. Mickey, and D.F. Paulson Isolation of a human prostate carcinoma cell line (DU 145) Int. J. Cancer 21 1978 274 281
31. O. Korchynskyi, and P. ten Dijke Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter J. Biol. Chem. 277 2002 4883 4891
32. D. Logeart-Avramoglou, M. Bourguignon, K. Oudina, P. Ten Dijke, and H. Petite An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct Anal. Biochem. 349 2006 78 86
33. A. Chen, Y.F. Kao, and C.M. Brown Translation of the first upstream ORF in the hepatitis B virus pregenomic RNA modulates translation at the core and polymerase initiation codons Nucleic Acids Res. 33 2005 1169 1181
34. M. Johnson, and B. Everitt Essential reproduction 1988 Blackwell Scientific Publications Oxford
35. L. Carim-Todd Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo J. Neurosci. 29 2009 678 685
36. B.M. Fenner Truncated TrkB: beyond a dominant negative receptor Cytokine Growth Factor Rev. 23 2012 15 24
37. M. Bibel, and Y.A. Barde Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system Genes Dev. 14 2000 2919 2937
38. I.S. McLennan, and J. Taylor-Jeffs The use of sodium lamps to brightly illuminate mouse houses during their dark phases Lab. Anim. 38 2004 1 9
39. A.N. Clarkson, C.L. Talbot, P.Y. Wang, D.T. Maclaughlin, P.K. Donahoe, and I.S. McLennan Mullerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons Exp. Neurol. 231 2011 304 308